PHAT earnings: a negative outcome, -8.1%

On May 10, 2022, Phathom Pharmaceuticals, Inc. reached its earnings. The result was a negative outcome, and the stock moved -8.1% in the window around the event. It had already run -23.7% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.